Petros Pharmaceuticals, Inc.
PTPI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815903
No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Petros Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 14 | 14 | 0 |
| Shares | 102.1K | 99.6K | −2.51K (−2.5%) |
| Value | $214.3K | $170.6K | −$43.8K (−20.4%) |
New holders (2)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 14,288 | $23.7K | 0.00% |
| Geode Capital Management, LLC | 10,502 | $17.4K | 0.00% |
Sold out (2)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Renaissance Technologies LLC | 16,779 | $34.0K |
| Bank of Montreal | 10,000 | $27.4K |